Cingulate
CING
8 hedge funds and large institutions have $129K invested in Cingulate in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
343% more capital invested
Capital invested by funds: $29.1K → $129K (+$99.8K)
100% more funds holding
Funds holding: 4 → 8 (+4)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.31% more ownership
Funds ownership: 0.03% → 0.35% (+0.31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$254K |
| 2 |
HF
HRT Financial
New York
|
+$28.6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$19.4K |
| 4 |
GA
GoalVest Advisory
New York
|
+$2.69K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$930 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$577 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$449 |
CING Hedge Fund Activity: Q1 2024 in Review
8 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cingulate (CING) for Q1 2024, worth a combined $129K — up 343% from $29.1K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CING positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $254K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $577 sold.
- 8 institutional investors held Cingulate (CING) as of Q1 2024, up from 4 in Q4 2023.
- Funds reported $129K of Cingulate stock for Q1 2024, up 343% quarter-over-quarter.
- 5 funds opened new Cingulate positions in Q1 2024 and 1 closed out, a net change of +4 holders.
- The largest Cingulate buyer in Q1 2024 was Cowen and Company, an estimated $254K added.
- The largest Cingulate seller in Q1 2024 was JP Morgan Chase, an estimated $577 sold.
Based on aggregated 13F filings for Q1 2024.